183 related articles for article (PubMed ID: 28986722)
1. Impact of the National Cervical Screening Programme in New Zealand by age: analysis of cervical cancer trends 1985-2013 in all women and in Māori women.
Smith MA; Edwards S; Canfell K
Cancer Causes Control; 2017 Dec; 28(12):1393-1404. PubMed ID: 28986722
[TBL] [Abstract][Full Text] [Related]
2. The effect of Māori ethnicity misclassification on cervical screening coverage.
Sandiford P; Salvetto M; Bramley D; Wong S; Johnson L
N Z Med J; 2013 Apr; 126(1372):55-65. PubMed ID: 23793178
[TBL] [Abstract][Full Text] [Related]
3. Potential for HPV vaccination and primary HPV screening to reduce cervical cancer disparities: Example from New Zealand.
Smith MA; Hall M; Lew JB; Canfell K
Vaccine; 2018 Oct; 36(42):6314-6324. PubMed ID: 30224201
[TBL] [Abstract][Full Text] [Related]
4. A review of cervical cancer occurrences in New Zealand 2008-2012.
Hider P; Dempster-Rivett K; Williman J; Dempster-Rivett M; Sadler L; McLeod M; Miller A; Sykes P
N Z Med J; 2018 Mar; 131(1472):53-63. PubMed ID: 29565936
[TBL] [Abstract][Full Text] [Related]
5. Improving survival disparities in cervical cancer between Māori and non-Māori women in New Zealand: a national retrospective cohort study.
McLeod M; Harris R; Purdie G; Cormack D; Robson B; Sykes P; Crengle S; Iupati D; Walker N
Aust N Z J Public Health; 2010 Apr; 34(2):193-9. PubMed ID: 23331365
[TBL] [Abstract][Full Text] [Related]
6. The impact of a two- versus three-yearly cervical screening interval recommendation on cervical cancer incidence and mortality: an analysis of trends in Australia, New Zealand, and England.
Simonella L; Canfell K
Cancer Causes Control; 2013 Sep; 24(9):1727-36. PubMed ID: 23832659
[TBL] [Abstract][Full Text] [Related]
7. Monitoring the performance of New Zealand's National Cervical Screening Programme through data linkage.
Lewis H; Yeh LC; Almendral B; Neal H
N Z Med J; 2009 Oct; 122(1305):15-25. PubMed ID: 19966874
[TBL] [Abstract][Full Text] [Related]
8. Impact of the Australian National Cervical Screening Program in women of different ages.
Smith M; Canfell K
Med J Aust; 2016 Oct; 205(8):359-364. PubMed ID: 27736623
[TBL] [Abstract][Full Text] [Related]
9. Human Papillomavirus (HPV) Self-Sampling among Never-and Under-Screened Indigenous Māori, Pacific and Asian Women in Aotearoa New Zealand: A Feasibility Study.
Bromhead C; Wihongi H; Sherman SM; Crengle S; Grant J; Martin G; Maxwell A; McPherson G; Puloka '; Reid S; Scott N; Bartholomew K
Int J Environ Res Public Health; 2021 Sep; 18(19):. PubMed ID: 34639352
[TBL] [Abstract][Full Text] [Related]
10. Achieving equitable outcomes for Māori women with cervical cancer in New Zealand: health provider views.
McLeod M; Cormack D; Harris R; Robson B; Sykes P; Crengle S
N Z Med J; 2011 May; 124(1334):52-62. PubMed ID: 21946636
[TBL] [Abstract][Full Text] [Related]
11. The impact of primary HPV screening on the incidence of cervical cancer in New Zealand.
Cox B; Fitzgerald P; Austin RM; Sneyd MJ
J Am Soc Cytopathol; 2019; 8(5):258-264. PubMed ID: 31543225
[TBL] [Abstract][Full Text] [Related]
12. Incidence of cancer among Pacific Island people in New Zealand.
Tukuitonga CF; Solomon N; Stewart A
N Z Med J; 1992 Nov; 105(946):463-6. PubMed ID: 1436871
[TBL] [Abstract][Full Text] [Related]
13. Impact of mammographic screening on ethnic and socioeconomic inequities in breast cancer stage at diagnosis and survival in New Zealand: a cohort study.
Seneviratne S; Campbell I; Scott N; Shirley R; Lawrenson R
BMC Public Health; 2015 Jan; 15():46. PubMed ID: 25637343
[TBL] [Abstract][Full Text] [Related]
14. Let's talk about smear tests: social marketing for the National Cervical Screening Programme.
Bethune GR; Lewis HJ
Public Health; 2009 Sep; 123 Suppl 1():e17-22. PubMed ID: 19740498
[TBL] [Abstract][Full Text] [Related]
15. Reaching under-screened/never-screened indigenous peoples with human papilloma virus self-testing: A community-based cluster randomised controlled trial.
MacDonald EJ; Geller S; Sibanda N; Stevenson K; Denmead L; Adcock A; Cram F; Hibma M; Sykes P; Lawton B
Aust N Z J Obstet Gynaecol; 2021 Feb; 61(1):135-141. PubMed ID: 33350455
[TBL] [Abstract][Full Text] [Related]
16. Ethnicity and birth outcome: New Zealand trends 1980-2001. Part 1. Introduction, methods, results and overview.
Craig ED; Mantell CD; Ekeroma AJ; Stewart AW; Mitchell EA
Aust N Z J Obstet Gynaecol; 2004 Dec; 44(6):530-6. PubMed ID: 15598291
[TBL] [Abstract][Full Text] [Related]
17. Demographic differences in stage at diagnosis and cervical cancer survival in New Zealand, 1994-2005.
Brewer N; Pearce N; Jeffreys M; White P; Ellison-Loschmann L
J Womens Health (Larchmt); 2009 Jul; 18(7):955-63. PubMed ID: 19580365
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of ovarian cancer in women residing in Aotearoa, New Zealand: 1993-2004.
Firestone RT; Wong KC; Ellison-Loschmann L; Pearce N; Jeffreys M
J Epidemiol Community Health; 2009 Oct; 63(10):814-9. PubMed ID: 19574244
[TBL] [Abstract][Full Text] [Related]
19. Investigating reasons for ethnic inequalities in breast cancer survival in New Zealand.
McKenzie F; Ellison-Loschmann L; Jeffreys M
Ethn Health; 2011 Dec; 16(6):535-49. PubMed ID: 21644117
[TBL] [Abstract][Full Text] [Related]
20. Determinants of inequalities in cervical cancer stage at diagnosis and survival in New Zealand.
Priest P; Sadler L; Sykes P; Marshall R; Peters J; Crengle S
Cancer Causes Control; 2010 Feb; 21(2):209-14. PubMed ID: 19847659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
